» Articles » PMID: 23963724

Attitudes and Knowledge of Primary Care Physicians Regarding Prostate Cancer Screening

Overview
Journal J Cancer Educ
Publisher Springer
Date 2013 Aug 22
PMID 23963724
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, several prospective randomized prostate cancer screening studies have been reported. We report the results of a questionnaire administered to primary care physicians (PCPs) to determine their attitudes on prostate cancer screening and compared these results to those obtained when the same questionnaire was administered to a different large cohort of PCPs in 2006 prior to the reporting of these randomized studies. A 24-item questionnaire designed to assess prostate cancer knowledge and screening attitudes was administered to PCPs within central Florida and those PCPs attending a state conference. Completed surveys were returned and analyzed. All reported p values were two-sided, and those p values less than 0.05 were considered to be statistically significant. Seven hundred and eighty PCPs received the study questionnaire, and 168 (22 %) PCPs returned the completed questionnaire. Sixty-eight percent of responders stated that they recommend prostate cancer screening to >75 % of their patients over the age of 50 years, up from 47 % in 2006 (p < 0.001). Seventy-four percent of responders felt screening was effective. The overall mean score of the knowledge survey was 66 %, which was similar to the cohort from 2006. Knowledge scores were not associated with screening attitudes and behaviors. On multivariate analysis, practice setting and percentage of Medicaid patients in the practice were associated with attitude scores. Our current findings imply that despite the recent landmark studies published on prostate cancer screening, PCPs' screening attitudes have changed minimally over the past 5 years.

Citing Articles

Knowledge, attitude and practice on screening and early diagnosis of prostate cancer of primary health care providers in the Free State.

Benedict M, Steinberg W, Claassen F, Mofolo N, van Rooyen C Afr J Prim Health Care Fam Med. 2023; 15(1):e1-e12.

PMID: 36861921 PMC: 9982489. DOI: 10.4102/phcfm.v15i1.3688.


Talking About Your Prostate: Perspectives from Providers and Community Members.

Choi S, Seel J, Steck S, Payne J, McCormick D, Schrock C J Cancer Educ. 2017; 33(5):1052-1060.

PMID: 28271389 PMC: 5589476. DOI: 10.1007/s13187-017-1205-8.


Knowledge and practice of prostate cancer screening among general practitioners in Malaysia: a cross-sectional study.

Tun Firzara A, Jenn Ng C BMJ Open. 2016; 6(9):e011467.

PMID: 27687897 PMC: 5051492. DOI: 10.1136/bmjopen-2016-011467.


Indicators of distress in newly diagnosed breast cancer patients.

Chirico A, Lucidi F, Mallia L, DAiuto M, Merluzzi T PeerJ. 2015; 3:e1107.

PMID: 26244115 PMC: 4517964. DOI: 10.7717/peerj.1107.

References
1.
Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M . Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009; 55(5):1037-63. DOI: 10.1016/j.eururo.2009.01.036. View

2.
Antonarakis E, Blackford A, Garrett-Mayer E, Eisenberger M . Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review. J Clin Oncol. 2007; 25(31):4998-5008. PMC: 4133788. DOI: 10.1200/JCO.2007.11.1559. View

3.
Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

4.
Arruda Viani G, Stefano E, Afonso S . Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys. 2009; 74(5):1405-18. DOI: 10.1016/j.ijrobp.2008.10.091. View

5.
Kellerman S, Herold J . Physician response to surveys. A review of the literature. Am J Prev Med. 2001; 20(1):61-7. DOI: 10.1016/s0749-3797(00)00258-0. View